Menopausal hormone therapy and risk of VTE and AD; patients' understanding of chemotherapy benefits; and FDA actions.
Menopausal hormone therapy and risk of VTE and AD; patients' understanding of chemotherapy benefits; and FDA actions.
Pharmacology Watch: Menopausal Hormone Therapy and the Risk for VTE, AD
December 1, 2012